UnitedHealth Group Incorporated (UNH)
Goldman Sachs Adds UnitedHealth to Its Conviction List: Is the Managed Care Comeback Real?
Goldman Sachs (NYSE:GS | GS Price Prediction) added UnitedHealth Group (NYSE:UNH) stock to its U.S.
UnitedHealth Pops 14.5% After Q1 Beat: Still a Buy or Too Late Now?
UNH surges 14.5% after a Q1 earnings beat and raised 2026 outlook, but membership declines, DOJ probes and valuation concerns could cap the rally.
UnitedHealth or Humana: Which Managed Care Stock Had the Healthiest Returns in April?
The April scoreboard is in for managed care. UnitedHealth Group (NYSE:UNH | UNH Price Prediction) stock and Humana (NYSE:HUM) stock both staged ferocious rallies, yet UnitedHealth won by roughly 56 basis points (bps).
Here is What to Know Beyond Why UnitedHealth Group Incorporated (UNH) is a Trending Stock
Zacks.com users have recently been watching UnitedHealth (UNH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
UnitedHealth and Humana Soar in April: Which Healthcare Stock Is Winning and Why
Shares of UnitedHealth Group (NYSE:UNH | UNH Price Prediction) are up 4% at midday Tuesday, trading near $368, while Humana (NYSE:HUM) stock is also up 4% to $233.
Goldman Sachs Lifts UnitedHealth Target Price: Healthcare ETFs to Watch
Goldman lifts UnitedHealth's target price, spotlighting ETFs like IHF as diversified ways to tap its growth while cushioning Medicaid-driven risks.
UnitedHealth: Solid Renewal Cadence With 2027 Tailwinds
UnitedHealth has delivered a solid renewal cadence as the premium repricing triggers the more sustainable membership base, the lower Medical Care Ratio, and the richer profit margins in FQ1 '26. This is aided by the higher-than-expected average payment hike for 2027 Medicare Advantage plans, with it driving the company's multi-year margin recovery tailwinds. UNH's multi-year recovery prospects may trigger near-term valuation noise, albeit worsened by the recent stock price rally and the overbought technical indicator.
UnitedHealth: Recovery Is Progressing, But Upside May Be Limited Near Term
UnitedHealth is in a margin recovery phase, with Q1 2026 results supporting a return to its historical 'beat and raise' pattern. UNH's medical care ratio improved to 83.9%, reinforcing the margin recovery thesis, though some improvements may be non-structural. Optum Health remains the key execution risk, with segment margins still challenged and visibility on recovery limited.
Jim Cramer Says UNH at $354 Is a Steal — Here's Why the Math Backs Him Up
Jim Cramer made UnitedHealth Group (NYSE: UNH | UNH Price Prediction) the centerpiece of his April 21 Mad Money show, arguing the managed care giant is back in fighting form after a brutal year.
Why UnitedHealth Group (UNH) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The Zacks Analyst Blog UnitedHealth, Morgan Stanley, RTX, Homes Group and Motorsport
Morgan Stanley???s capital markets strength and wealth management push drive momentum, but rising expenses and trading volatility could test future growth.
Why UnitedHealth Group (UNH) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
